Zura Bio Ltd (ZURA) stock
ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.95−0.01 (-1.32%)
Close on Nov 19, 2026Market cap $91.74MP/E –Yield –
Zura Bio total assets
Total assets on the balance sheet at the end of each period.
Zura Bio's total assets was $194.63M at Sep 30, 2026. For fiscal 2025 it was $113.95M, down 36.5% from the year before. The highest annual figure on record is $179.53M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $113.95M | -36.5% |
| FY2024 | Dec 31, 2024 | $179.53M | +78.0% |
| FY2023 | Dec 31, 2023 | $100.84M | +1816.4% |
| FY2022 | Dec 31, 2022 | $5.26M | -96.3% |
| FY2021 | Dec 31, 2021 | $140.55M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $194.63M | +35.2% |
| Q2 FY2026 | Jun 30, 2026 | $213.40M | +35.2% |
| Q1 FY2026 | Mar 31, 2026 | $228.64M | +32.5% |
| Q4 FY2025 | Dec 31, 2025 | $113.95M | -36.5% |
| Q3 FY2025 | Sep 30, 2025 | $143.94M | -23.9% |
| Q2 FY2025 | Jun 30, 2025 | $157.81M | -16.7% |
| Q1 FY2025 | Mar 31, 2025 | $172.50M | +90.6% |
| Q4 FY2024 | Dec 31, 2024 | $179.53M | +78.0% |
| Q3 FY2024 | Sep 30, 2024 | $189.07M | +80.8% |
| Q2 FY2024 | Jun 30, 2024 | $189.50M | +67.2% |
| Q1 FY2024 | Mar 31, 2024 | $90.48M | +103.9% |
| Q4 FY2023 | Dec 31, 2023 | $100.84M | +1816.4% |
| Q3 FY2023 | Sep 30, 2023 | $104.59M | -25.5% |
| Q2 FY2023 | Jun 30, 2023 | $113.33M | -19.1% |
| Q1 FY2023 | Mar 31, 2023 | $44.39M | -68.4% |
| Q4 FY2022 | Dec 31, 2022 | $5.26M | -96.3% |
| Q3 FY2022 | Sep 30, 2022 | $140.48M | -0.3% |
| Q2 FY2022 | Jun 30, 2022 | $140.03M | +84893.8% |
| Q1 FY2022 | Mar 31, 2022 | $140.25M | +146645.8% |
| Q4 FY2021 | Dec 31, 2021 | $140.55M | – |
| Q3 FY2021 | Sep 30, 2021 | $140.91M | – |
| Q2 FY2021 | Jun 30, 2021 | $164.76K | – |
| Q1 FY2021 | Mar 31, 2021 | $95.58K | – |
See a number that looks wrong?